Summary of this article
Anlon Healthcare shares are commanding a grey market premium (GMP) ranging between Rs 2 and Rs 6 per share
Anlon Healthcare Ltd seeks to raise Rs 121.03 crore by undertaking the fresh issuance of 13.3 million shares.
Anlon Healthcare IPO bidding window opened on August 26 and is scheduled to close on August 29.
The bidding window for Anlon Healthcare IPO (Anlon Healthcare Ltd) is scheduled to close today, on August 29. The pharmaceutical issue is witnessing strong demand on the third and final day of subscription.
The drugmaker’s issue has received bids for over 81.34 million shares so far against the 13.3 million shares offered for subscription, leading to the issue being booked 6.12 times at the time of writing.
Anlon Healthcare IPO GMP
Anlon Healthcare shares are commanding a grey market premium (GMP) ranging between Rs 2 and Rs 6 per share, according to various websites which monitor the movement of unlisted shares. Given the GMP of Rs 6, Anlon Healthcare shares are likely to make a muted debut with a premium of 6.59 per cent at Rs 97 per share.
Anlon Healthcare IPO: Subscription On Day 3
Retail Individual Investors (RIIs) oversubscribed their quota in the Anlon Healthcare IPO 41.28 times on the final day of bidding. Retail investors applied for over 54.89 million shares of Anlon Healthcare Ltd compared to the 1.33 million shares reserved for the category.Non-Institutional Investors (NIIs) applied for over 15.85 million shares against the 1.99 million shares set aside for them. The pharmaceutical company’s issue was booked 7.95 times in the NII category. Qualified Institutional Buyers (QIBs) applied for 10.59 million shares of the pharma company on the last day of bidding against the 9.97 million shares set aside for the category and booked the issue 1.06 times.
Anlon Healthcare IPO: Offer Size and Price Band
Anlon Healthcare Ltd seeks to raise Rs 121.03 crore by undertaking the fresh issuance of 13.3 million shares. Anlon Healthcare IPO price band was fixed at Rs 86 to Rs 91 per share.Anlon Healthcare IPO: Lot Size and Minimum InvestmentRetail investors interested in applying for Anlon Healthcare IPO can place bids for a minimum of 164 shares, which aggregates to an investment of Rs 14,924. The minimum lot size for Small Non-Institutional Investors (SNIIs) interested in applying for Anlon Healthcare IPO is 14 lots or 2,296 shares, amounting to an investment of Rs 208,936.
Anlon Healthcare IPO: Subscription window, listing date, allotment date
Anlon Healthcare IPO bidding window opened on August 26. Anlon Healthcare IPO bidding window is scheduled to close on August 29. The share allotment status of Anlon Healthcare IPO will be announced on September 1. Subsequently, the pharma company will issue refunds for unsuccessful applicants on September 2. Successful bidders will receive shares of Anlon Healthcare in their demat accounts on September 2 as well. Anlon Healthcare’s shares will make their D-street debut on the NSE and BSE. Anlon Healthcare Ltd shares are scheduled to list on the bourses on September 3.
Anlon Healthcare: Key financials
Anlon Healthcare’s total income for FY25 stood at Rs 120.46 crore, increasing by over 80 per cent from Rs 66.69 crore in FY24. The healthcare company’s profit-after-tax increased by over 112 per cent to Rs 20.52 crore in FY25 compared to Rs 9.66 crore in the preceding fiscal. Anlon Healthcare’s net worth increased by over 282 per cent to Rs 80.42 crore in FY25 compared to Rs 21.03 crore in FY24.
Anlon Healthcare IPO: Registrar
Anlon Healthcare IPO book running lead manager is Interactive Financial Services Ltd and the registrar for the issue is Kfin Technologies Ltd.
Anlon Healthcare: Promoters
Promoters of Anlon Healthcare include Punitkumar Rasadia, Meet Atulkumar Vachhani and Mamata Punit Kumar Rasadia. The promoters held 70.26 per cent stake in the company prior to the public issue and will reduce their stake to 52.68 per cent post the issue.
Anlon Healthcare IPO: Objective
Anlon Healthcare plans to use the money raised via the public issue to fund its capital expenditure needs and working capital requirements. The pharmaceutical company also plans to use the funds for repayment of outstanding secured borrowings and general corporate purposes.
About Anlon Healthcare Ltd
Anlon Healthcare Ltd makes and markets certain pharmaceutical goods such as Pharma Intermediates and active pharmaceutical ingredients (APIs). The pharmaceutical goods made by the company are used by several industries such as medicines, nutraceuticals, personal care, and veterinary products.
